We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.82%
2 Consumer Discretionary 12.47%
3 Healthcare 12.19%
4 Financials 11.52%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCVX icon
1801
Vaxcyte
PCVX
$8.76B
$272K ﹤0.01%
11,417
ANGO icon
1802
AngioDynamics
ANGO
$647M
$271K ﹤0.01%
9,829
CCRN
1803
DELISTED
Cross Country Healthcare
CCRN
$271K ﹤0.01%
9,761
BATRK icon
1804
Atlanta Braves Holdings Series B
BATRK
$3.41B
$271K ﹤0.01%
9,642
-1,676
-15% -$47.5K
XENT
1805
DELISTED
Intersect ENT, Inc
XENT
$271K ﹤0.01%
9,918
PPC icon
1806
Pilgrim's Pride
PPC
$6.4B
$271K ﹤0.01%
9,601
-188
-2% -$5.35K
ATRI
1807
DELISTED
Atrion Corp
ATRI
$270K ﹤0.01%
383
OEC icon
1808
Orion
OEC
$364M
$270K ﹤0.01%
14,690
-828
-5% -$15.4K
ESLT icon
1809
Elbit Systems
ESLT
$36.5B
$269K ﹤0.01%
1,553
LASR icon
1810
nLIGHT
LASR
$2.9B
$269K ﹤0.01%
11,218
BRMK
1811
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$269K ﹤0.01%
28,491
+216
+0.8% +$2.13K
ECOL
1812
DELISTED
US Ecology, Inc.
ECOL
$269K ﹤0.01%
8,408
IONS icon
1813
Ionis Pharmaceuticals
IONS
$9.39B
$268K ﹤0.01%
8,813
-67
-0.8% -$2.11K
WMK icon
1814
Weis Markets
WMK
$1.78B
$268K ﹤0.01%
4,069
-679
-14% -$41.2K
NIC icon
1815
Nicolet Bankshares
NIC
$3.72B
$268K ﹤0.01%
3,125
-277
-8% -$21.1K
MCB icon
1816
Metropolitan Bank Holding Corp
MCB
$1.17B
$268K ﹤0.01%
2,512
+192
+8% +$18.3K
BLNK icon
1817
Blink Charging
BLNK
$87.1M
$267K ﹤0.01%
10,086
ALLO icon
1818
Allogene Therapeutics
ALLO
$683M
$267K ﹤0.01%
17,914
-1,136
-6% -$20K
CCO icon
1819
Clear Channel Outdoor Holdings
CCO
$1.23B
$266K ﹤0.01%
80,276
+3,846
+5% +$12K
RADI
1820
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
$266K ﹤0.01%
16,496
AROC icon
1821
Archrock
AROC
$5.84B
$265K ﹤0.01%
35,405
SNEX icon
1822
StoneX
SNEX
$8.05B
$264K ﹤0.01%
21,789
COWN
1823
DELISTED
Cowen Inc. Class A Common Stock
COWN
$263K ﹤0.01%
7,297
NXGN
1824
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$263K ﹤0.01%
14,806
-2,576
-15% -$41.4K
CXW icon
1825
CoreCivic
CXW
$3.32B
$263K ﹤0.01%
26,398
+578
+2% +$5.74K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.